Selene Manga - Infectious Diseases

Author Information

S. Manga is affiliated with the Department of Infectious Diseases at the University National San Antonio Abad Cusco, located in Cusco, Peru. The author's work is pivotal in the field of infectious diseases, with a particular focus on tuberculosis (TB), including drug-resistant strains and the implementation of innovative treatment strategies.

Research Contributions

The author has made significant contributions to tuberculosis research, with a strong emphasis on the diagnosis, treatment, and prevention of TB infection. S. Manga has actively participated in extensive research focused on drug-resistant tuberculosis and has explored innovative treatment options, including the use of drugs like bedaquiline and delamanid. Furthermore, the author has contributed to global studies on adverse events related to TB treatments, the TB situation in Latin America, and TB control in specific settings such as prisons and among migrants.

Aliases

The author is known by several aliases, including S Manga, S. Manga, and Selene Manga.

Publication and Citation Metrics

Metric	Value
Total Papers	17
Total Citations	499
h-index	7

Publications:

Clinical standards for the diagnosis, treatment and prevention of TB infection

DOI: 10.5588/ijtld.21.0753

Year: 2022

TB research and innovation in Latin America

DOI: 10.1183/16000617.0107-2020

Year: 2021

Tuberculosis and Prisons

DOI: 10.1007/978-3-030-66703-0_22

Year: 2021

Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network

DOI: 10.3390/antibiotics10111355

Year: 2021

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.

DOI: 10.1016/j.pulmoe.2021.02.006

Year: 2021

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

DOI: 10.1016/j.ijid.2019.03.036

Year: 2019

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

DOI: 10.1183/13993003.01522-2019

Year: 2019

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.

DOI: 10.1016/j.jinf.2018.08.003

Year: 2019

Outcomes of drug-resistant TB cases undergoing bedaquiline (BQ)-treatment and adjunctive surgery

DOI: 10.1183/13993003.CONGRESS-2018.PA3672

Year: 2018

Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results

DOI: 10.1183/1393003.CONGRESS-2017.OA4852

Year: 2017

How Do Pathogens Evade the Immune System?

What is the Current Research Focus?

What Role Do Extreme Weather Events Play?

What Measures Can Be Taken to Control the Spread?

What Measures Can Individuals Take to Protect Themselves from Infectious Diseases?

Can Climate Change Affect Mosquito-Borne Diseases?

Can STIs Affect Pregnancy?

Can Targeting Metabolic Pathways Serve as a Therapeutic Strategy?

What Challenges Exist in Measles Control?

How Can Malaria Be Prevented?

Partnered Content Networks

Relevant Topics